Advertisement

Topics

Companies Related to "Genes That Contribute ADHD Development Discovered" [Most Relevant Company Matches] RSS

01:34 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "Genes That Contribute ADHD Development Discovered" found in our extensive corporate database of over 50,000 company records.

Showing "Genes That Contribute ADHD Development Discovered" Companies 1–25 of 6,200+

Relevant

CHADD

CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder) is the leading resource on attention-deficit/hyperactivity disorder (ADHD), providing support, training, education and advocacy for the 17 million children and adults in the United States living with ADHD, their families, educators and healthcare professionals. As home to the Nationa...


Hyseq Incorporated

Hyseq, Inc. is a biopharmaceutical company with a growing pipeline of product candidates in its genomics-based HyProfileportfolio. The primary product candidates are expressed proteins of novel rare genes discovered through applications of the Company's proprietary HyX platform in conjunction with work performed by its Functional Genomics, Protein Purification and Bioinformatics Groups. The Compan...

Chlorogen

The idea that culminated in the founding of Chlorogen in 2002 began in the mid 1980s. That's when molecular biologist Professor Henry Daniell became interested in the developing field of plant biotechnology. While he recognized the tremendous potential for plants to produce beneficial novel proteins for foods, medicines and industrial uses, he questioned whether there was a risk that foreign genes...


BioBehavioral Diagnostics Company

BioBehavioral Diagnostics Company manufactures and markets the Quotient(TM) ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptoms. We are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhance quality of life for patients with ADHD. Our vision is to provide accurate tools for the diagnosi...

Metamark Genetics, Inc.

Metamark is a privately held oncology company focused on the development of function-based prognostic assays for early staged cancers. The MetamarkDx(TM) Prognostic Assays under development are based on Metamark's proprietary Prognosis Determinants(TM), genes discovered through leading edge cancer research and demonstrated to play a causal role in promoting tumor progression and spread. For furthe...

McNeil Pediatrics(TM)

McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is committed to meeting the needs of children, adolescents, adults and healthcare professionals through the development of therapies specifically formulated for children, adolescents and adults. McNeil Pediatrics(TM) is a leader in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and markets a leading me...

Human Genome Sciences Incorporated

Human Genome Sciences, Inc. is engaged in the research and development of novel, proprietary pharmaceutical and diagnostic products based on the discovery and understanding of the medical utility of genes. Using automated, high-throughput gene sequencing technology, the Company has generated a very large collection of partial human gene sequences, which the Company believes correspond to most of t...

Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s extensive expertise in product development has been built over the past 20 years: initially as a stand alone development organization, then as a U.S. subsid...

Highland Therapeutics Inc.

Highland Therapeutics Inc. is a specialty pharmaceutical company that, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc., is leveraging its proprietary technology, DELEXIS™, to optimize the delivery of previously approved drug products. The Company’s lead product candidates, HLD-200 and HLD-100, are novel formulati...

Kissei Pharmaceutical Co., Ltd

We at Kissei, as our management philosophy, hope to contribute to freeing people from the pain and suffering of disease. And for the past half century since our founding, we have moved ever forward with research into original medications, continuing with the development of new pharmaceutical products which contribute to the advancement of medical science. The needs for medical therapy for people a...

Blu Genes Foundation

Blu Genes Foundation was established to advance research in gene therapy for genetic disorders, offering hope where currently there is none. This need is the driving force behind Blu Genes Foundation’s mission. Gene therapy research takes dedicated time and funding support to bring treatments from bench to bedside.

AltheaDx, Inc.

AltheaDx is a commercial stage molecular diagnostics company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx’s Research Services’ NGS portfolio includes pre-qualified panels such as AOP™150, Cancer Hotspo...

Dyadic International

Dyadic International, Inc. is a global biotechnology company with the groundbreaking technology that brings nature to the marketplace. Dyadic is focused on the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms - including humans - found in the earth’s biodiversity. Using its integrated technology platform, Dyadic develops biological pr...

Mendel Biotechnology, Inc

Mendel Biotechnology was founded in early 1997 to develop the idea that controlling gene expression would create new opportunities to improve plant growth and development. We have focused on a large class of genes called transcription factors because they control the degree to which each gene in a cell is activated. The approximately 27,000 genes in the Arabidopsis genome are controlled by approxi...

WM-data

Our mission explains why we exist and work in our chosen market. And what we would ultimately like to contribute. Everything we do within WM-data is done with the purpose of increasing our customers’ competitive edge. Our aim is for our services and solutions to contribute to increased efficiency within both the private and public sectors. Resources, for example, in the form of money, time and w...

Global Genes

Global Genes is a non-profit organization that operates as one of the leading rare disease patient advocacy groups in the world. Global Genes promotes the needs of the Rare Disease Community under a unifying symbol of hope—the Blue Denim Genes Ribbon™. The organization was born out of humble beginnings, emerging as a grassroots movement in 2009 comprise...

RepairGenes

The aim of the repairGenes site is to be a source of information about DNA repair genes and a useful resource for research on DNA repair.At the moment, the site contains information about a number of DNA repair genes from a set of selected species. The information is organised by organism and by biological process term as defined by the Gene Ontology (GO) project. The coverage of DNA repair genes ...

Nura Inc.

Nura is a development stage biotechnology company focused on the discovery of therapeutics for behavioral disorders and neurodegenerative diseases.We have established an in-house drug discovery platform focused on G Protein-Coupled Receptors (GPCRs) and Phosphodiesterase (PDE) by examining and focusing on those genes expressed in specific locations, either preferentially or selectively, in both mo...

The Child and Adult Diagnostic and Treatment Program for ADHD

NextWave Pharmaceuticals

NextWave is an emerging specialty pharmaceutical company primarily focused on the development and commercialization of unique products for the treatment of cardiovascular and CNS diseases, with a pipeline of investigational drug candidates targeted for ADHD and related disorders. More information about NextWave is available at www.nextwavepharma.com.

Weiner Consulting Services, LLC

Weiner Consulting Services, LLC was formed to provide a new level of affordable services to the healthcare industry. Hal Weiner, President, has over 40 years of experience in development, planning, management, implementation, sales and marketing of healthcare information services. We are dedicated to creating services that contribute to the financial success of your organization. Our services can...

CompleGen

We are an early stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.Our system is used to build compound discovery systems for a broad range of therapeutic targets for the pharmaceutical industry, as well as efficient cost-effective product discovery systems for the agricultural industry. We have discovered, developed, and patented ...

Quark Biotech, Inc.

Quark Biotech, Inc., is a biopharmaceutical company headquartered in the U.S., focused on the development of drugs based in its proprietary target genes.Quark has developed a broad technology portfolio covering fundamental drug discovery techniques as well as numerous specific disease targets. Through innovative combinations of gene silencing and DNA microarray technology, Quark has pioneered and ...

Medarex

Medarex is an integrated monoclonal antibody-based company with antibody discovery, development and manufacturing capabilities. Utilizing its HuMAb-Mouse(TM) system, Medarex has the ability to make fully-human antibodies in a transgenic mouse whose mouse genes for creating antibodies have been inactivated and replaced by human antibody genes. The Company has entered into ten corporate partnering a...

Gliatech Incorporated

Gliatech is engaged in the research, development and commercialization of ADCON, a family of proprietary, resorbable, carbohydrate polymer medical devices designed to inhibit surgical scarring and adhesions. In addition to the ADCON family of medical devices, the Company is pursuing the development of small molecule drug candidates for the treatment of several central nervous system disorders, inc...


More From BioPortfolio on "Genes That Contribute ADHD Development Discovered"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks